Citation Impact
Citing Papers
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
UALCAN: An update to the integrated cancer data analysis platform
2022 Standout
Cancer statistics, 2019
2019 Standout
The Epidemiology of Obesity: A Big Picture
2014 Standout
Expanding global access to radiotherapy
2015 Standout
Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy
2001
The Link between Smoking and Impotence: Two Decades of Evidence
2001
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer
2006
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Erectile Dysfunction
2000 Standout
Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer
2012
Nomograms in oncology: more than meets the eye
2015 Standout
The association between obesity and the progression of prostate and renal cell carcinoma
2004
Urinary diversion in high-risk elderly patients: Modified cutaneous ureterostomy or ileal conduit?
2005
Head and neck cancer
2008 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Obesity and cancer
2008
Epidemiology of Prostate Cancer
2019 Standout
Surrogate End Point for Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation Therapy
2003
Transcriptional Profiling of Human Endogenous Retrovirus Group HERV-K(HML-2) Loci in Melanoma
2013
T1G3 Bladder Tumours: The Case for Conservative Treatment
2003
Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin‐like growth factor binding protein‐3 levels
2007
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Genetic diversity in farm animals – a review
2010 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2005 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2015 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Obesity and mortality in men with locally advanced prostate cancer
2007
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Trends in Reporting Gleason Score 1991 to 2001: Changes in the Pathologist's Practice
2004
Trazodone for the Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors
2008
Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction
2002
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients: A Review of 17 Randomized Controlled Trials
2008
Multitargeted therapy of cancer by silymarin
2008 Standout
The impact of socioeconomic status on survival after cancer in the United States
2008
Are Findings from Studies of Obesity and Prostate Cancer Really in Conflict?
2006
Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies
2012
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Fifteen-Year Biochemical Relapse-Free Survival, Cause-Specific Survival, and Overall Survival Following I125 Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle Experience
2010
Epidemiology of prostate cancer
2003
Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing‐hormone releasing hormone agonist treatment for prostate cancer
2008
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Defining the Need for Breast Cancer Radiotherapy in the General Population: a Criterion-based Benchmarking Approach
2007
Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data
2007
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
2006 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer—Do Outcomes Differ?
2017
Germ-Line Genetic Variation in the Key Androgen-Regulating Genes Androgen Receptor, Cytochrome P450, and Steroid-5-α-Reductase Type 2 Is Important for Prostate Cancer Development
2006
Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk
2015
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
TESTOSTERONE REPLACEMENT THERAPY AFTER PRIMARY TREATMENT FOR PROSTATE CANCER
2005
Abundant mtDNA Diversity and Ancestral Admixture in Colombian criollo Cattle (Bos taurus)
2003
Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens
2005
PROSTATE SPECIFIC ANTIGEN DOUBLING TIME AS A SURROGATE END POINT FOR PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING RADICAL PROSTATECTOMY OR RADIATION THERAPY
2004
Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
2009
Decision aids for people facing health treatment or screening decisions
2017 Standout
Vitamin D and Prostate Cancer
2002
Pharmacology of Penile Erection
2001
Vitamin D and cancer: a review of molecular mechanisms
2011
Telomerase activation: one step on the road to cancer?
1999 StandoutNobel
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.
2003
Cancer statistics, 2014
2014 Standout
Biomedical Importance of Indoles
2013 Standout
Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists
2020
Early Versus Delayed Hormonal Therapy for Prostate Specific Antigen Only Recurrence of Prostate Cancer After Radical Prostatectomy
2004
Molecular mechanisms involving prostate cancer racial disparity.
2017
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer
2021
Works of Raymond Lance being referenced
Regulation of proliferation of prostate epithelial cells by 1,25-dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3
2001
Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: An overview of the Department of Defense Center for Prostate Disease Research national database
2002
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer
2015
Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system
2003
DNA methylation profiles in African American prostate cancer patients in relation to disease progression
2016
Radical cystectomy for invasive bladder cancer in the octogenarian
2001
Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database
2003
Adenocarcinoma of the prostate: an expensive way to die
2002
Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the center for prostate disease research nomograms
2003
Effect of Race on Biochemical Disease-free Outcome in Patients with Prostate Cancer Treated with Definitive Radiation Therapy in an Equal-Access Health Care System: Radiation Oncology Report of the Department of Defense Center for Prostate Disease Research
2002
The association between telomerase, p53, and clinical staging in colorectal cancer
1998
Oral trazodone as empirical therapy for erectile dysfunction: a retrospective review
1995
Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer
2010
Gene expression panel predicts metastatic‐lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer
2016
Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines
2011
Feasibility of using guidelines to choose treatment for prostate cancer.
2010
PARENTERAL MEDROXYPROGESTERONE FOR THE MANAGEMENT OF LUTEINIZING HORMONE RELEASING HORMONE INDUCED HOT FLASHES IN MEN WITH ADVANCED PROSTATE CANCER
2005
Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy
2003
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
2015
Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era
2001
Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen Era
2003